Lumiliximab (Synonyms: PRIMATIZED ANTI-CD23; GOMILIXIMAB [USAN])

Cat.#: 176932

Size:

Special Price 112.9 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Lumiliximab (Synonyms: PRIMATIZED ANTI-CD23; GOMILIXIMAB [USAN])
  • Documents
  • Description
    Anti-FceR2 / CD23 Antibody (Lumiliximab)
  • Tested applications
    ELISA
  • Species reactivity
    Human FceR2 / CD23
  • Alternative names
    PRIMATIZED ANTI-CD23 antibody; GOMILIXIMAB [USAN] antibody
  • Isotype
    IgG1
  • Preparation
    Recombinant expression and purified from CHO cells.
  • Clonality
    Monoclonal
  • Formulation
    0.1 M Pro-Ac, 20 mM Arg, pH 5.0
  • Storage instructions
    -80°C for 2 years under sterile conditions; -20°C for 1 year under sterile conditions; Avoid repeated freeze-thaw cycles.
  • Validations

    SDS-PAGE

    SDS-PAGE

    Anti-FceR2 / CD23 Antibody (lumiliximab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.

    SEC-HPLC

    SEC-HPLC

    The purity of Anti-FceR2 / CD23 Antibody (lumiliximab) is 100%, determined by SEC-HPLC.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"